NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

Publisher Name :
Date: 27-Sep-2019
No. of pages: 140
Inquire Before Buying

“The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.”

The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA sequencing industry.

Pharmaceutical & biotechnology companies segment to witness the highest growth in the NGS-based RNA-sequencing market during the forecast period.

Based on the end-user, the NGS-based RNA-sequencing industry is segmented into research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness highest growth rate during the forecast period mainly due to growing number of agreements and collaborations between NGS market players and pharmaceutical & biotechnology companies for the development of advanced products.

“Expression profiling analysis application to hold the largest share in the NGS-based RNA-sequencing market.

Based on application, the NGS-based market is segmented into expression profiling analysis, small RNA-sequencing, de novo transcript me assembly, and variant calling & transcriptase epigenetic. In 2018, the expression profiling analysis segment accounted for the largest share mainly due to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases will propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

“The Asia Pacific market is expected to witness the highest CAGR during the forecast period.”

The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.

Breakdown of supply-side primary interviews:


  • By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%

  • By Designation: C-level: 47%, D-level:33%, and Others:20%

  • By Region: North America:35%, Europe: 32%, APAC: 25%,Latin America: 6% and Middle East & Africa: 2%


The major players operating in the NGS-based RNA-sequencing market areIllumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market

Research Coverage

This report studies the NGS-based RNA-sequencing market based on product & service, technology, application, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micro markets with respect to their growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa(and the respective countries in these regions).

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis—market ranking analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the NGS-based RNA-sequencing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key data from secondary sources
2.1.2 Primary Data
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Top-down Approach
2.2.2 Bottom-up Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions and Limitations
2.4.1 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.2 Key Market Restraints
5.3.3 Key Market Opportunities
5.3.4 Key Market Challenges

6 NGS based RNA-Seq Market, By Products & Services
6.1 Introduction
6.2 Sample Preparation
6.2.1 By Workflow
6.2.1.1 Library preparation & target enrichment
6.2.1.1 Quality control
6.2.2 By Method
6.2.2.1 Manual sample preparation
6.2.2.2 Microfluidic sample preparation
6.2.2.3 Robotic liquid handling sample preparation
6.3 RNA sequencing platforms & consumables
6.4 RNA sequencing Services
6.5 Data Analysis, Storage & Management

7 NGS based RNA-Seq Market, by Sequencing Type
7.1 Introduction
7.2 Sequencing by synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single Molecular Real Time Sequencing
7.5 Nanopopre Sequencing

8 NGS based RNA-Seq Market, By Application
8.1 Introduction
8.2 Expression profiling analysis
8.3 Small RNA sequencing
8.4 De novo transcriptome assembly
8.5 Variant calling & transcriptome epigenetics

9 NGS based RNA-Seq Market, By End User
9.1 Introduction
9.2 Research & Academia
9.3 Hospitals & Clinics
9.4 Biotechnology & Pharmaceutical Companies
9.5 Other End Users

10 NGS based RNA-Seq Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Rest of Europe
10.4 Asia-Pacific
10.4.1 India
10.4.2 China
10.4.3 Japan
10.4.4 Rest of Asia-Pacific (RoAPAC)
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 RoLATAM
10.6 Middle East & Africa

11 Competitive Landscape
11.1 Introduction
11.2 NGS based RNA-Seq Market Share, by top 5 players (2018)
11.3 Competitive Scenario (2016-2019)
11.3.1 New Products Launches and Product Enhancements
11.3.2 Agreements, Partnerships, and Agreements
11.3.3 Mergers and Acquisitions
11.3.4 Geographic Expansions
11.4 Competitive Leadership Mapping (Overall Market)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
11.5 Competitive Leadership Mapping (Emerging Players)
11.5.1 Progressive companies
11.5.2 Starting/emerging blocks
11.5.3 Responsive companies
11.5.4 Dynamic companies

12 Company Profiles
12.1 Introduction (2016-2019)
12.2 Agilent Technologies
12.3 BGI
12.4 Eurofins Scientific
12.5 GENEWIZ, Inc.
12.6 Hamilton Company
12.7 Illumina
12.8 Nugene
12.9 Oxford Nanopore Technologies
12.10 Perkinelmer
12.11 Psmogen
12.13 Qiagen
12.14 Roche
12.15 Takara Holdings Inc.
12.16 Thermo Fisher Scientific
12.17 Zymo Research

13 Appendix
13.1 Insights from Key Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real-time Market Intelligence
13.4 Available Cutomizations
13.5 Related Reports

  • Global RNAi for Therapeutic Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 131
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global Targeted RNA Sequencing Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 18-Nov-2019        Price: US 2900 Onwards        Pages: 184
    The Targeted RNA Sequencing market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Targeted RNA Sequencing. Global Targeted RNA Sequencing industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, mark......
  • Global RNAi for Therapeutic Market Study 2016-2026, by Segment (siRNA, miRNA,) , by Market (Cancer, Cardiovascular,) , by Company (Alnylam Pharmaceuticals, Arrowhead,)
    Published: 17-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024
    Published: 01-Nov-2019        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 2802.7 million by 2024, from US$ 1186.9 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by ......
  • Global RNAi For Therapeutic Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 113
    The RNAi for Therapeutic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the RNAi for Therapeutic industrial chain, this report mainly elaborates the definition, types, applications and major players of RNAi for Therapeutic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ind......
  • Global RNA In Situ Hybridization Market Professional Survey Report 2019
    Published: 17-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global RNA In Situ Hybridization market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on RNA In Situ Hybridization volume and value at global level, regional level and company level. From a global perspective, this report represents overall RNA In Situ Hybridization market size by analyzing historical data and future prospect. Regionally, this report categorizes the production,......
  • Global Antisense and RNAi Therapeutics Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the......
  • NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
    Published: 27-Sep-2019        Price: US 4950 Onwards        Pages: 140
    “The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.” The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA ......
  • Global Rnai Therapeutics Industry Market Research Report
    Published: 26-Sep-2019        Price: US 2960 Onwards        Pages: 122
    The Rnai Therapeutics market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Rnai Therapeutics industrial chain, this report mainly elaborates the definition, types, applications and major players of Rnai Therapeutics market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry dev......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs